Post Injection Pain on Test E: What's Normal, by Day

What the label says about pain at the injection site

'Test E' usually means testosterone enanthate, while the label detail on this page comes from the cypionate product Depo-Testosterone. Enanthate products carry their own labels.

Depo-Testosterone is testosterone cypionate dissolved in cottonseed oil with benzyl benzoate and benzyl alcohol, supplied as 100 mg/mL and 200 mg/mL [1]. The label directs that it be given intramuscularly, never intravenously, deep in the gluteal muscle, at 50 to 400 mg every 2 to 4 weeks [1].

The adverse reactions section closes with a single line: 'Miscellaneous: Inflammation and pain at the site of intramuscular injection' [1]. The label gives no percentage, no hour of onset, no peak and no resolution date for it.

What to note on the day of the injection

Record the product, strength, injection site and any redness or swelling. The label says to inspect the solution for particulate matter and discoloration before administration whenever solution and container permit [1].

CDC's safe injection guidance calls for aseptic technique and a sterile, single-use, disposable needle and syringe for each injection [4]. These are infection-prevention measures.

Warning signs after an injection

MedlinePlus's guide to intramuscular injections lists a lump, bruise or swelling at the injection site that does not go away, and fever or feeling unwell after an injection, as reasons to contact a provider [2]. It lists a rash, intense itching, trouble breathing, or swelling of the mouth, lips or face as reasons to call 911 or the local emergency number right away [2].

One label warning sits close to this subject. Testosterone labeling says to evaluate patients who report pain, edema, warmth and erythema in the lower extremity for deep vein thrombosis, and those with acute shortness of breath for pulmonary embolism [1]. That concerns the leg and breathing, not the gluteal injection site.

Does subcutaneous injection hurt less?

The route-and-pain studies are small and were done in transgender adults, not in men with hypogonadism on cypionate every two to four weeks.

A prospective open-label crossover pilot gave 14 transgender men (mean age 30) intramuscular testosterone cypionate or enanthate for three weeks, then subcutaneous injections for eight weeks. Total testosterone exposure was comparable between routes, and weekly questionnaires showed lower self-reported scores for pre-injection anxiety, pain during injection and post-injection pain in the subcutaneous phase [3].

A retrospective cohort of 63 transgender patients on weekly subcutaneous cypionate or enanthate recorded minor, transient local reactions in 9 of 63. Of 22 who had previously used intramuscular injections, all 22 preferred the subcutaneous route, 20 markedly so [5].

Depo-Testosterone itself is labeled for deep gluteal intramuscular use [1].

Could it be the oil, the preservative or an allergy?

The Depo-Testosterone vial contains cottonseed oil, benzyl benzoate, benzyl alcohol and the cypionate ester [1]. A 2024 case report is titled 'Delayed hypersensitivity reaction to testosterone cypionate injections'; one case report gives no rate for that reaction [7].

What to track instead of a calendar

Track the direction of pain, the size of any redness or swelling, fever, drainage, bruising and whether walking or sitting is affected, along with the product, site, volume and who gave the injection.